Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Ugur AkcaDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
Patrick N SongDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
Dattatray DevalankarDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
Norio YasuiDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
Anna G SoraceDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
Jonathan McConathyDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama; jmcconathy@uabmc.edu.
Funding
XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
UAB Predoctoral Training Grant in Translational and Molecular SciencesT32GM135028 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Mythreye Karthikeyan, RAKESH P. PATEL · 2021 to 2026
$1.6M
Personalizing immunotherapy in HER2+ breast cancer through quantitative imagingR01CA240589 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SORACE, ANNA C · 2020 to 2023
$1.6M
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancerR01CA276540 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SORACE, ANNA C, YANKEELOV, THOMAS E · 2023 to 2025
$1.4M
Novel fluorinated amino ester prodrugs for PET imaging of gliomasR21CA234764 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MCCONATHY, JONATHAN EDWARD · 2019 to 2020
Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen and progesterone receptors and low expression of the human epidermal growth factor receptor 2 gene. Radiolabeled amino acids (AAs) have the ability to specifically target the enhanced AA transport and modified metabolic pathways present in breast cancer cells. The primary objective of this study was to compare the uptake of AA PET tracers targeting different AA transporter systems in 2 mouse models to assess their potential for imaging TNBC.
Indexed as
Amino AcidsAmino Acid Transport SystemsFluorine RadioisotopesPositron-Emission TomographyTriple Negative Breast NeoplasmsAnimalsBiological TransportCell Line, TumorFemaleHumansIsotope LabelingMiceRadiopharmaceuticalsTissue DistributionAmino AcidsAmino Acid Transport SystemsFluorine-18Fluorine RadioisotopesRadiopharmaceuticalsAFETPbreast cancerfluciclovineMeFAMPradiolabeled amino acids
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Preclinical Comparison of · full record | OpenQuestion